More on NAMS
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $30.15 |
|
|||
| Open | $31.21 | ||||
| 52 Wk High | $0.00 | ||||
| 52 Wk Low | $0.00 | ||||
| Day High | $31.25 | ||||
| Day Low | $29.64 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 1,250,184 | ||||
- NewAmsterdam Pharma Announces Upcoming Presentations at the National Lipid Association (NLA) 2026 Scientific Sessions
- NewAmsterdam Pharma to Participate at Upcoming Investor Conferences in June
- Form 4 NewAmsterdam Pharma Co For: May 26 Filed by: Kooij Louise Frederika
- Piper Sandler's Thoughts on NewAmsterdam Pharma Co NV (NAMS) Post Investor Dinner
- NewAmsterdam Pharma to Participate at Upcoming Investor Conferences in May
- NewAmsterdam Pharma Co NV (NAMS) PT Raised to $52 at Cantor Fitzgerald
- NewAmsterdam Pharma Company N.V. (NAMS) reported Q1 Revenue
- NewAmsterdam Pharma Provides Corporate Update and Reports First Quarter Financial Results
- NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- NewAmsterdam Pharma to Present at the 25th Annual Needham Virtual Healthcare Conference
Entities mentioned with NAMS
- Definitive Agreement | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- SPAC | View Related Stories »
- Jefferies & Co | View Related Stories »
- F1 | View Related Stories »
- Earnings | View Related Stories »
- Show More...
